Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01725269 |
Recruitment Status
:
Terminated
(Terminated early dt acquisition of Sponsor and change in corporate priorities)
First Posted
: November 12, 2012
Last Update Posted
: April 9, 2014
|
Sponsor:
Aires Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Aires Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | April 2014 |
Actual Study Completion Date : | April 2014 |
Publications:
Hassoun, PM. Pulmonary arterial hypertension complicating connective tissue disease. In: Humbert M., Lynch JP, Eds. Pulmonary Hypertension. New York: Informa Healthcare USA, Inc. 2010: 161-175.
Levi, DS, Scott, V, Aboulhosn J. Pulmonary arterial hypertension in congenital heart disease. In: Humbert, M, Lynch, JP, Eds. Pulmonary Hypertension. New York: Informa Healthcare USA, Inc. 2010: 176-195.
Ware, JE et al. How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: QualityMetric, Incorporated, 2000.